Absci (ABSI) Capital Expenditures (2020 - 2026)
Absci's (ABSI) quarterly Capital Expenditures came in at $30000.0 in Q1 2026, up 20.0% year-on-year from $25000.0 in Q1 2025, and up 129.13% quarter-over-quarter from -$103000.0 in Q4 2025.
Absci (ABSI) Capital Expenditures (2020 - 2026) Analysis & Trends
Absci has disclosed Capital Expenditures across 7 years of filings, most recently posting $30000.0 for Q1 2026.
- Capital Expenditures for Q1 2026 came in at $30000.0, up 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 96.81% YoY), and the FY2025 annual result was $1.1 million, up 105.0% from the prior year.
- Capital Expenditures came in at $30000.0 for Q1 2026 at Absci, up from -$103000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $7.5 million in Q2 2022 to a low of -$15.5 million in Q4 2022.
- The 5-year median for Capital Expenditures is $191000.0 (2024), against an average of $166250.0.
- Peak annual rise in Capital Expenditures reached 1904.17% in 2025, while the deepest fall reached 164.78% in 2025.
- Absci's Capital Expenditures stood at -$15.5 million in 2022, then soared by 100.11% to $17000.0 in 2023, then jumped by 835.29% to $159000.0 in 2024, then plunged by 164.78% to -$103000.0 in 2025, then jumped by 129.13% to $30000.0 in 2026.
- The last three Capital Expenditures figures came in at $30000.0 (Q1 2026), -$103000.0 (Q4 2025), and $962000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Sep 30, 2025 | 962,000.00 |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 307,000.00 |
| Sep 30, 2023 | 307,000.00 |